XML 83 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2022
Oct. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2023
Mar. 31, 2022
Feb. 28, 2021
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]                  
Weighted average grant date fair value (in dollars per share)     $ 20.36            
Weighted average exercise price of options exercisable     $ 59.46            
Weighted average remaining contractual life of options exercisable     1 year 10 months 17 days            
Aggregate intrinsic value of options exercisable     $ 10,100,000            
Straight line basis over the requisite     3 years            
Aggregate cost     $ 3,000,000.0            
Percentage of increase in annual dividend   20.00%              
Dividends payable, amount per share (in Dollars per share)   $ 1.32              
Subsequent Event [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)           $ 0.625      
interparfums S A [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate cost     4,100,000            
Board of Directors Chairman [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Dividends payable, amount per share (in Dollars per share)               $ 2.50  
Interparfums SA Subsidiary [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Shares adjusted for stock splits 211,955                
Recognized as compensation cost     $ 4,800,000            
Interparfums SA Subsidiary [Member] | Employees [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding                 $ 133,000
Adjusted for stock splits (in shares)     63,281       88,400   26,600
Number of share distributed     85,062            
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Number of shares available for grant (in shares)     558,975            
Aggregate intrinsic value of options outstanding     $ 13,000,000.0            
Term     5 years            
Stock Option One [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Aggregate intrinsic value of options outstanding     $ 2,700,000            
Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Fair value of shares vested     $ 1,300,000 $ 1,400,000 $ 1,700,000        
Weighted average grant date fair value (in dollars per share)     $ 20.36 $ 11.35 $ 12.16        
Minimum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period     4 years            
Maximum [Member] | Equity Option [Member]                  
Subsidiary or Equity Method Investee [Line Items]                  
Share-based compensation arrangement by share-based payment award, award vesting period     5 years